Robert L. VITTI,Kristine A. ERICKSON,Karen W. CHU,Stanley J. WIEGAND,Jingtai CAO,Ivan B. LOBOV,Saurabh WADHWA,Kenneth S. GRAHAM,Daniel DIX
申请号：
US14943490
公开号：
US20160144025A1
申请日:
2015.11.17
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention provides methods for treating, preventing or reducing the severity of an eye disease. The methods of the present invention comprise administering to a subject in need thereof a therapeutic composition comprising an angiopoietin-2 (Ang-2) inhibitor such as an anti-Ang-2 antibody in combination with a vascular endothelial growth factor (VEGF) antagonist (e.g., aflibercept).
